CEO Dr. Carl Schwartz of Skyline Medical Inc. and CEO Dr. James Garvin of CytoBioscience Inc. discuss upcoming merger.
|CEO Dr. Carl Schwartz of Skyline Medical Inc. (NASDAQ: SKLN)|
CEO Dr. Carl Schwartz of Skyline Medical Inc. (NASDAQ: SKLN), and CEO Dr. James Garvin of CytoBioscience Inc., join Stock Day to discuss upcoming merger.
About Skyline Medical Inc.
Skyline Medical Inc. has a fully automated, patented, and FDA cleared surgical fluid disposal device– the STREAMWAY System– that virtually eliminates operating room workers’ exposure to blood, irrigation fluid and other potentially infectious fluids found in the surgical environment.
Today’s manual surgical fluid handling methods of hand-carrying filled surgical fluid canisters and emptying these canisters is an exposure risk and an antiquated approach to the handling of surgical fluid waste. Skyline’s STREAMWAY System fully automates the collection, measurement and disposal of surgical fluids, which results in:
Skyline’s STREAMWAY System is eco-friendly as it addresses the numerous bloody, potentially disease infected canisters that go into U.S. landfills every year. These tainted canisters– which are generally made of plastic– can take centuries to biodegrade, but with installations of the STREAMWAY System, the number of these canisters can be significantly reduced.
Quality Management System – ISO 13485:2003
The CEOs interviewed on the Stock Day Podcast did not incur any charges for their time with Uptick Newswire CEO Everett Jolly. Contact us at (602) 441-3474 if you would like further information.
Source: Uptick Newswire